Myocardial Inotropic Agents I and II Flashcards

1
Q

By what mechanism do all FDA approved inotropes act?

A

by increasing intracellular calcium and cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does beta receptor modulation affect calcium levels in myocytes?

A

agonist activity at beta receptor can increase cAMP which increases calcium via PKA-mediated phosphorylation of phospholamban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does PDE modulation affect calcium levels in myocytes?

A

PDE-3 inhibitors block degradation of cAMP to AMP allowing for greater PKA-mediated phosphorylation of phospholamban to increase calcium stores

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does addition of an inotrope do the starling curve (stroke volume vs. EDV/preload)?

A

moves curve up and to the left (improves contractility)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does addition of a vasodilator do the starling curve (stroke volume vs. EDV/preload)?

A

moves curve up and to the left (improves contractility by reducing afterload)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does addition of a vasodilator and inotrope do the starling curve (stroke volume vs. EDV/preload)?

A

moves curve up and to the left b/c of synergistic contractility improving effects of both drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does addition of a diuretic do the starling curve (stroke volume vs. EDV/preload)?

A

shift along curve to left b/c reducing volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most commonly prescribed heart failure medicine and how does it work?

A

digoxin –> binds to Na/K atpase –> increases intracellular Na –> increased action by Na/Ca exchanger –> increased intracellular calcium causing increased inotropy without increasing HR

*upward and left shift of starling curve)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do normal levels of extracellular potassium do to efficacy of digoxin?

A

reduces –> competitively decreases digoxin binding and may be protective in digoxin toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does hypokalemia do to efficacy of digoxin?

A

unlike at higher levels/normal potassium which is protective, hypokalemia may increase both effect and toxicity of digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the concern with desensitization/tolerance of digoxin?

A

none –> it’s pretty unique in that you don’t get desensitized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do low doses of digoxin affect mortality risk?

A

does not at LOW doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is digoxin administered and how is it cleared?

A

oral administration, renal elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the therapeutic level of digoxin?

A

.5-1 (some textbooks say up to 2 but that is dangerous) –> keep levels low!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hemodynamic effects of digoxin

A

increased cardiac output, increased LV ejection fraction, increased exercise tolerance, increased natriuresis

decreased LVEDP/preload, decreased neurohormonal activation (reduce norepi, RAAS activity, increased vagal tone/normalization of baroreceptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adverse effects of digoxin

A
  1. increased vagal tone reducing AV node automatcity leading to bradycardia and heart block
  2. at toxic doses, increase sympathetic tone and directly increase automaticity and delayed after polarizations leading to ventricular tachycardia and fibrillation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What was the main lesson from the dig trial?

A

you have to control digoxin dose for body surface area or you end up with lots of toxic side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clinical uses of digoxin

A

a-fib with rapid ventricular response, CHF symptoms despite medical therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why must we exercise caution when using digoxin with a beta blocker?

A

risk of bradycardia and heart block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Does the factor predispose or protect against digoxin toxicity? hypokalemia

A

predispose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Does the factor predispose or protect against digoxin toxicity? hypokalemia

A

predispose

21
Q

Does the factor predispose or protect against digoxin toxicity? hyperkalemia

A

predispose

21
Q

Does the factor predispose or protect against digoxin toxicity? hypomagnesia

A

predispose

22
Q

Does the factor predispose or protect against digoxin toxicity? hyperkalemia

22
Contraindications to digoxin use
1. toxicity without pacemakers: 2. advanced av block 3. bradcardia or sick sinus syndrome 4. ventricular arrhythmias 5. marked hypokalemia 5. wolf-parkinson-white w/ afib
23
Classic rhythm of digoxin toxcity
atrial tachycardia w/ av block
23
Tx of digoxin toxicity
antibody to digoxin, increase potassium
24
Does the factor predispose or protect against digoxin toxicity? hypoxia and acidosis
predispose
24
Does the factor predispose or protect against digoxin toxicity? hypoxia and acidosis
predispose
25
Contraindications to digoxin use
1. toxicity without pacemakers: 2. advanced av block 3. bradcardia or sick sinus syndrome 4. ventricular arrhythmias 5. marked hypokalemia 5. wolf-parkinson-white w/ afib
26
Classic rhythm of digoxin toxcity
atrial tachycardia w/ av block
27
Tx of digoxin toxicity
antibody to digoxin, increase potassium
33
Side effects of dopamine
dose dependent tachycardia, htn, nausea, iv site necrosis/gangrene due to alpha vasoconstriction
34
Dopamine antidote
phentolamine
35
What is the problem with continuous administration of dopamine or dobutamine?
desensitization
36
How do beta blockers interact with dobutamine and dopamine?
beta blockers inhibit these drugs --> need higher doses of dobutamine/dopamine to overcome effect but also increase side effect risk
37
Are dobutamine/dopamine short/long half life? is this good or bad?
short half life --> advantage b/c allows for real time monitoring/modulation
38
Side effects of dobutamine
arrhythmia, ischemia/angina, hypOtension, tachycardia, rapid ventricular response in afib due to increase in AV conduction, nausea, headache
39
Why is epinephrine not commonly used in heart failure therapy?
it is non selective and can lead to tachyphylaxis
40
How does PDE3I differ in peripheral arterial system and in myocytes?
in myocytes--> upregulates cAMP to increase contractility but in peripheral arterial system cAMP reduces contractility/increases vasodilation
41
How is the parameter affected by PDE3I? cardiac index
increased
42
How is the parameter affected by PDE3I? SVR/MAP
decreased
43
How is the parameter affected by PDE3I? PAWP/LVEDP
decreased
44
How is the parameter affected by PDE3I? heart rate
not much change
45
How is the parameter affected by PDE3I? ventricular dP/dT/performance
increased
46
Side effects of PDE3I
hypotension if filling pressures are not elevated due to venodilator properties of inhibitors which drop pre/afterload simultaneously
47
Main risk associated with amrinone
causes thrombocytopenia in pts with advanced heart failure
48
Administration of milrinone
bolus + infusion but risk of bolus is acute hypotension
49
Elimination of milrinone
kidney --> bad renal clearance in heart failure patients can reduce infusion rate
50
How do oral PDE3I affect mortality?
increase mortality despite great hemodynamic effects in hospital